⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Zensar Technologies and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Zensar Technologies
↗Pune, India
Zensar Technologies is a leading global technology consulting and IT services company headquartered in Pune, India. Part of the RPG Group, the company specializes in digital transformation, offering services across application management, cloud infrastructure, data engineering, artificial intelligence, and cybersecurity to clients in industries such as banking, manufacturing, retail, and healthcare.
In recent years, Zensar has significantly expanded its Healthcare and Life Sciences (HLS) practice, notably through the 2024 acquisition of BridgeView Life Sciences. The company provides specialized technology solutions for pharmaceutical, biotechnology, and medical device companies, including support for clinical trials, regulatory intelligence, commercialization, and product launches.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:IT Services & Consulting for Life Sciences
SIZE & FINANCIALS
Employees:10000+
Revenue:$600M-$700M
Founded:1991
Ownership:public
Status:operating
FUNDING
Total Raised:$9M
Investors:RPG Group
STOCK
Exchange:BSE, NSE
Ticker:ZENSARTECH
Market Cap:$1.3B
0
CORPORATE STRUCTURE
Parent Company:RPG Group
Subsidiaries:BridgeView Life Sciences
Key Partnerships:Veeva Systems (Commercial/Development Cloud), Salesforce, Reltio, Datavant, Snowflake, IQVIA
COMPETITION
Position:Challenger
Competitors:IBM, UST, Mindtree
LEADERSHIP
Key Executives:
Manish Tandon - CEO and Managing Director
Harsh Goenka - Chairman
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Zensar Technologies. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.